RecallRadar

FDA Drug recall D-1492-2016

Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc

On 2016-09-14 the FDA classified a Class III recall of Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc by Lupin, citing CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1492-2016
ClassificationClass III
Statusterminated
Initiated2016-02-19
Published2016-09-14
Last updated2026-09-13 11:51 UTC
CompanyLupin
Distributionn/a

Product

Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Goa 403 722 INDIA, NDC 68180-750-09

Reason

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Identifiers

ndc68180-750-09
ndc68180-751-09
ndc68180-751-03
ndc68180-751-17
ndc68180-752-09
ndc68180-752-03
ndc68180-719-03
ndc68180-719-09
ndc68180-720-09
ndc68180-720-03
ndc68180-721-03
ndc68180-721-09
ndc68180-233-01
ndc68180-233-02
ndc68180-455-02
ndc68180-455-01
code_infoLot #: G304799, Exp. 4/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1492-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.